Nurse-led pre-test counseling for Alzheimer's disease biomarker testing: Knowledge and skills required to meet the needs of patients and families

•Biomarker tests for Alzheimer's disease (AD) pathology are proliferating.•Pre-test counseling (PTC) for AD biomarker testing is an emerging role for nurses.•Key functions of PTC include disease-specific education and emotional support.•Nurse-led PTC yields rich exchanges with patients and fami...

Full description

Saved in:
Bibliographic Details
Published inGeriatric nursing (New York) Vol. 53; pp. 130 - 134
Main Authors Greer, Olivia, Cheng, Rebekah, Tamres, Lisa K., Mattos, Meghan, Morris, Jonna L., Knox, Melissa L., Lingler, Jennifer H.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.09.2023
Subjects
Alzheimer Disease - diagnosis
Alzheimer's disease
Amyloid PET
Biomarkers
Cognitive Dysfunction - psychology
Counseling
Humans
Mild cognitive impairment
Nurse's Role
Nurse-patient communication
Patient education
Positron-Emission Tomography - methods
Patient education
Nurse-patient communication
Mild cognitive impairment
Amyloid PET
Alzheimer's disease
Online AccessGet full text

Cover

Abstract •Biomarker tests for Alzheimer's disease (AD) pathology are proliferating.•Pre-test counseling (PTC) for AD biomarker testing is an emerging role for nurses.•Key functions of PTC include disease-specific education and emotional support.•Nurse-led PTC yields rich exchanges with patients and family members and promotes informed decision-making. Biomarker testing for Alzheimer's disease and related disorders (ADRD) brings new opportunities for nurses to foster shared decision-making by leading pre-test counseling (PTC) for patients and families. Audio-recordings of 18 nurse-led PTC sessions were analyzed to characterize questions posed by patient and family members dyads considering whether to pursue amyloid positron emission tomography. Sessions lasted 20 to 75 minutes and generated rich discussion of the purpose and potential implications of amyloid imaging. Dyads posed questions regarding: basic neuroanatomy; the spectrum of normal cognitive aging to dementia; clinical phenotypes and pathological hallmarks of ADRD; secondary prevention of ADRD; and advance planning. In response, PTC facilitators provided disease-specific education, clarification of overt misconceptions, caregiver support, and emotion de-escalation. Nurses conducting PTC for AD biomarker testing should be equipped to answer questions about topics both directly and indirectly related to testing, and also provide emotional support.
AbstractList INTRODUCTIONBiomarker testing for Alzheimer's disease and related disorders (ADRD) brings new opportunities for nurses to foster shared decision-making by leading pre-test counseling (PTC) for patients and families.METHODSAudio-recordings of 18 nurse-led PTC sessions were analyzed to characterize questions posed by patient and family members dyads considering whether to pursue amyloid positron emission tomography.RESULTSSessions lasted 20 to 75 minutes and generated rich discussion of the purpose and potential implications of amyloid imaging. Dyads posed questions regarding: basic neuroanatomy; the spectrum of normal cognitive aging to dementia; clinical phenotypes and pathological hallmarks of ADRD; secondary prevention of ADRD; and advance planning. In response, PTC facilitators provided disease-specific education, clarification of overt misconceptions, caregiver support, and emotion de-escalation.CONCLUSIONNurses conducting PTC for AD biomarker testing should be equipped to answer questions about topics both directly and indirectly related to testing, and also provide emotional support.
Biomarker testing for Alzheimer's disease and related disorders (ADRD) brings new opportunities for nurses to foster shared decision-making by leading pre-test counseling (PTC) for patients and families. Audio-recordings of 18 nurse-led PTC sessions were analyzed to characterize questions posed by patient and family members dyads considering whether to pursue amyloid positron emission tomography. Sessions lasted 20 to 75 minutes and generated rich discussion of the purpose and potential implications of amyloid imaging. Dyads posed questions regarding: basic neuroanatomy; the spectrum of normal cognitive aging to dementia; clinical phenotypes and pathological hallmarks of ADRD; secondary prevention of ADRD; and advance planning. In response, PTC facilitators provided disease-specific education, clarification of overt misconceptions, caregiver support, and emotion de-escalation. Nurses conducting PTC for AD biomarker testing should be equipped to answer questions about topics both directly and indirectly related to testing, and also provide emotional support.
•Biomarker tests for Alzheimer's disease (AD) pathology are proliferating.•Pre-test counseling (PTC) for AD biomarker testing is an emerging role for nurses.•Key functions of PTC include disease-specific education and emotional support.•Nurse-led PTC yields rich exchanges with patients and family members and promotes informed decision-making. Biomarker testing for Alzheimer's disease and related disorders (ADRD) brings new opportunities for nurses to foster shared decision-making by leading pre-test counseling (PTC) for patients and families. Audio-recordings of 18 nurse-led PTC sessions were analyzed to characterize questions posed by patient and family members dyads considering whether to pursue amyloid positron emission tomography. Sessions lasted 20 to 75 minutes and generated rich discussion of the purpose and potential implications of amyloid imaging. Dyads posed questions regarding: basic neuroanatomy; the spectrum of normal cognitive aging to dementia; clinical phenotypes and pathological hallmarks of ADRD; secondary prevention of ADRD; and advance planning. In response, PTC facilitators provided disease-specific education, clarification of overt misconceptions, caregiver support, and emotion de-escalation. Nurses conducting PTC for AD biomarker testing should be equipped to answer questions about topics both directly and indirectly related to testing, and also provide emotional support.
Author Greer, Olivia
Lingler, Jennifer H.
Tamres, Lisa K.
Mattos, Meghan
Morris, Jonna L.
Cheng, Rebekah
Knox, Melissa L.
AuthorAffiliation c University of Pittsburgh School of Nursing, Pittsburgh, PA, USA
b UPMC Western Psychiatric Institute and Clinic, Pittsburgh, PA, USA
d University of Virginia School of Nursing, Charlottesville, VA, USA
a Children’s Hospital of Philadelphia, Philadelphia, PA, USA
AuthorAffiliation_xml – name: c University of Pittsburgh School of Nursing, Pittsburgh, PA, USA
– name: d University of Virginia School of Nursing, Charlottesville, VA, USA
– name: a Children’s Hospital of Philadelphia, Philadelphia, PA, USA
– name: b UPMC Western Psychiatric Institute and Clinic, Pittsburgh, PA, USA
Author_xml – sequence: 1
  givenname: Olivia
  surname: Greer
  fullname: Greer, Olivia
  organization: Children's Hospital of Philadelphia, Philadelphia, PA, USA
– sequence: 2
  givenname: Rebekah
  surname: Cheng
  fullname: Cheng, Rebekah
  organization: UPMC Western Psychiatric Institute and Clinic, Pittsburgh, PA, USA
– sequence: 3
  givenname: Lisa K.
  surname: Tamres
  fullname: Tamres, Lisa K.
  organization: University of Pittsburgh School of Nursing, Pittsburgh, PA, USA
– sequence: 4
  givenname: Meghan
  orcidid: 0000-0001-7355-7190
  surname: Mattos
  fullname: Mattos, Meghan
  organization: University of Virginia School of Nursing, Charlottesville, VA, USA
– sequence: 5
  givenname: Jonna L.
  orcidid: 0000-0002-4150-9407
  surname: Morris
  fullname: Morris, Jonna L.
  organization: University of Pittsburgh School of Nursing, Pittsburgh, PA, USA
– sequence: 6
  givenname: Melissa L.
  surname: Knox
  fullname: Knox, Melissa L.
  organization: University of Pittsburgh School of Nursing, Pittsburgh, PA, USA
– sequence: 7
  givenname: Jennifer H.
  orcidid: 0000-0003-3226-7722
  surname: Lingler
  fullname: Lingler, Jennifer H.
  email: linglerj@pitt.edu
  organization: University of Pittsburgh School of Nursing, Pittsburgh, PA, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37540906$$D View this record in MEDLINE/PubMed
BookMark eNqFkc1u1DAUhS1URKeFVwDvYJPgnyRO2KBRxZ-oYANry7GvZzx17KmdFMFb8MZ4mDKCFSsvfM537z3nAp2FGAChZ5TUlNDu5a7eQHJhSRlqRhiviagJEQ_Qirasr_jQN2doReggqqYV7Bxd5LwjhAy854_QORdtQwbSrdDPTwdG5cHgfYJqhjxjHZeQwbuwwTYmvPY_tuAmSM8zNi6DyoBHFyeVbiDhg6MoX-GPIX4rmA1gFQzON877jBPcLi4V-BzxBDDjeQs4AJiMo8V7NTsIc_7tsGpy3kF-jB5a5TM8uX8v0de3b75cva-uP7_7cLW-rnTD2FwZPrbNAG3fj8LqVgETVJFeq27glJq2Y7YlIDTng6HKWM207UB3lo6j4h3wS_T6yN0v4wRGl0WS8nKfXLnsu4zKyX9_gtvKTbyTlAhKBesK4cU9IcXbpeQgJ5c1eK8CxCVL1jfdwFrR8iIVR6lOMecE9jSHEnloVO7kqVF5aFQSIUujxfn07zVPvj8VFsH6KIAS1p2DJLMuqWowJXg9SxPdf4f8AnsDva4
Cites_doi 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G
10.1016/j.jalz.2016.09.014
10.1093/brain/awn016
10.1186/s13195-018-0425-4
10.1001/jama.2019.2000
10.1093/geront/gnac051
10.1093/geront/46.6.791
10.1212/WNL.0000000000201389
10.1001/archneur.56.3.303
10.3390/cells11081367
10.1002/trc2.12002
10.1002/alz.12129
10.1186/s13195-017-0321-3
10.1016/j.jalz.2018.02.018
10.1002/alz.12444
10.1002/nur.4770180211
ContentType Journal Article
Copyright 2023 The Author(s)
Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.
Copyright_xml – notice: 2023 The Author(s)
– notice: Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.
DBID 6I.
AAFTH
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
DOI 10.1016/j.gerinurse.2023.07.007
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Social Welfare & Social Work
Nursing
EISSN 1528-3984
EndPage 134
ExternalDocumentID 10_1016_j_gerinurse_2023_07_007
37540906
S0197457223001775
Genre Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIA NIH HHS
  grantid: P30 AG066468
– fundername: NIA NIH HHS
  grantid: P50 AG005133
– fundername: NIA NIH HHS
  grantid: R01 AG046906
GroupedDBID ---
--K
--M
-~X
.GJ
.~1
0-6
07C
0R~
186
1B1
1~.
1~5
2KS
4.4
457
4G.
53G
5GY
5RE
5VS
6I.
7-5
71M
85S
8P~
9JM
AABSN
AACTN
AAEDT
AAEDW
AAFTH
AAGJQ
AAIAV
AAIKC
AAIKJ
AAKOC
AALRI
AAMNW
AAOAW
AAQFI
AAQQT
AAQXK
AAWTL
AAXUO
ABBQC
ABFRF
ABJNI
ABLJU
ABLVK
ABMAC
ABMZM
ABOCM
ABPIV
ABXDB
ABYKQ
ACDAQ
ACGFO
ACGFS
ACHQT
ACJTP
ACNCT
ACRLP
ADBBV
ADEZE
ADMHC
ADMUD
AEBSH
AEFWE
AEKER
AENEX
AFDAS
AFFNX
AFKWA
AFTJW
AFXBA
AFXIZ
AGHFR
AGNAY
AGUBO
AGYEJ
AHHHB
AIDAL
AIDBO
AIEXJ
AIKHN
AISVY
AITUG
AJBFU
AJOXV
AJRQY
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
C45
CAG
COF
COPKO
CS3
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
EX3
F5P
FAFAN
FD6
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HVGLF
HZ~
H~9
IHE
J1W
K-O
KOM
LCYCR
LPU
M2W
M41
MO0
N9A
NAHTW
NEJ
NHB
O-L
O9-
OAUVE
OEN
OHT
OMK
OVD
OZT
P-8
P-9
P2P
PC.
PQQKQ
Q38
QZG
R2-
RIG
ROL
RPZ
SDF
SDG
SDP
SEL
SES
SEW
SJN
SKT
SNC
SND
SNG
SNH
SPCBC
SSH
SSZ
T5K
TEORI
TWZ
UGJ
UHS
UKR
UMD
UNMZH
VVN
WH7
WOW
WUQ
X7L
XCE
XZL
YCJ
YFH
YOC
YYQ
YZZ
ZGI
ZHY
ZUP
~A~
~G-
~G0
AAXKI
ADUKH
AFJKZ
AKRWK
CGR
CUY
CVF
ECM
EIF
NPM
WAC
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-c422t-d3b549e588b7fc5ae271a08ca69311d562f50e7c339d1adfc2cf6ec6f1bba36e3
IEDL.DBID AIKHN
ISSN 0197-4572
IngestDate Tue Sep 17 21:29:23 EDT 2024
Fri Oct 25 22:40:09 EDT 2024
Thu Sep 26 17:03:05 EDT 2024
Sat Nov 02 12:06:50 EDT 2024
Fri Feb 23 02:34:46 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords Patient education
Nurse-patient communication
Mild cognitive impairment
Amyloid PET
Alzheimer's disease
Language English
License This is an open access article under the CC BY-NC-ND license.
Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c422t-d3b549e588b7fc5ae271a08ca69311d562f50e7c339d1adfc2cf6ec6f1bba36e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-4150-9407
0000-0001-7355-7190
0000-0003-3226-7722
OpenAccessLink https://www.sciencedirect.com/science/article/pii/S0197457223001775
PMID 37540906
PQID 2846925753
PQPubID 23479
PageCount 5
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_10711726
proquest_miscellaneous_2846925753
crossref_primary_10_1016_j_gerinurse_2023_07_007
pubmed_primary_37540906
elsevier_sciencedirect_doi_10_1016_j_gerinurse_2023_07_007
PublicationCentury 2000
PublicationDate 2023-09-01
PublicationDateYYYYMMDD 2023-09-01
PublicationDate_xml – month: 09
  year: 2023
  text: 2023-09-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Geriatric nursing (New York)
PublicationTitleAlternate Geriatr Nurs
PublicationYear 2023
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Vanderschaeghe, Schaeverbeke, Bruffaerts, Vandenberghe, Dierickx (bib0004) 2017; 9
Lingler, Roberts, Kim (bib0007) 2018; 10
Sandelowski (bib0014) 1995; 18
Ikonomovic, Klunk, Abrahamson (bib0015) 2008; 131
Varesi, Carrara, Pires (bib0017) 2022; 11
Bélanger, D'Silva, Carroll (bib0006) 2023; 63
Lingler, Sereika, Butters (bib0013) 2020; 16
Sandelowski (bib0012) 2000; 23
Rabinovici, Gatsonis, Apgar (bib0019) 2019; 321
O'Bryant, Mielke, Rissman (bib0002) 2017; 13
Petersen, Smith, Waring, Ivnik, Tangalos, Kokmen (bib0011) 1999; 56
Shimohama, Tezuka, Takahata (bib0020) 2023; 100
(bib0003) 2009
Christensen, KD, Karlawish, J, Roberts, JS, et al. Disclosing genetic risk for Alzheimer's dementia to individuals with mild cognitive impairment. Alzheimer's Dement. 2020; 6:e12002.
Largent, Karlawish, Grill (bib0018) 2018; 10
Cummings, Apostolova, Rabinovici (bib0010) 2023; 10
Lingler, Nightingale, Erlen, Kane, Reynolds, Schulz, DeKosky (bib0016) 2006; 46
Cummings, Salloway (bib0009) 2022; 18
Berkowitz, Mosconi, Rahman, Scheyer, Hristov, Isaacson (bib0008) 2018; 5
Jack, Bennett, Blennow (bib0001) 2018; 14
Berkowitz (10.1016/j.gerinurse.2023.07.007_bib0008) 2018; 5
Petersen (10.1016/j.gerinurse.2023.07.007_bib0011) 1999; 56
Cummings (10.1016/j.gerinurse.2023.07.007_bib0009) 2022; 18
Lingler (10.1016/j.gerinurse.2023.07.007_bib0016) 2006; 46
10.1016/j.gerinurse.2023.07.007_bib0005
Lingler (10.1016/j.gerinurse.2023.07.007_bib0007) 2018; 10
Shimohama (10.1016/j.gerinurse.2023.07.007_bib0020) 2023; 100
O'Bryant (10.1016/j.gerinurse.2023.07.007_bib0002) 2017; 13
Bélanger (10.1016/j.gerinurse.2023.07.007_bib0006) 2023; 63
Ikonomovic (10.1016/j.gerinurse.2023.07.007_bib0015) 2008; 131
Cummings (10.1016/j.gerinurse.2023.07.007_bib0010) 2023; 10
Sandelowski (10.1016/j.gerinurse.2023.07.007_bib0012) 2000; 23
Vanderschaeghe (10.1016/j.gerinurse.2023.07.007_bib0004) 2017; 9
(10.1016/j.gerinurse.2023.07.007_bib0003) 2009
Lingler (10.1016/j.gerinurse.2023.07.007_bib0013) 2020; 16
Rabinovici (10.1016/j.gerinurse.2023.07.007_bib0019) 2019; 321
Varesi (10.1016/j.gerinurse.2023.07.007_bib0017) 2022; 11
Largent (10.1016/j.gerinurse.2023.07.007_bib0018) 2018; 10
Sandelowski (10.1016/j.gerinurse.2023.07.007_bib0014) 1995; 18
Jack (10.1016/j.gerinurse.2023.07.007_bib0001) 2018; 14
References_xml – volume: 321
  start-page: 1286
  year: 2019
  end-page: 1294
  ident: bib0019
  article-title: Association of amyloid positron emission tomography with subsequent change in clinical management among medicare beneficiaries with mild cognitive impairment or dementia
  publication-title: JAMA
  contributor:
    fullname: Apgar
– volume: 56
  year: 1999
  ident: bib0011
  article-title: Mild cognitive impairment: clinical characterization and outcome
  publication-title: Arch Neurol
  contributor:
    fullname: Kokmen
– volume: 23
  start-page: 334
  year: 2000
  end-page: 340
  ident: bib0012
  article-title: Whatever happened to qualitative description?
  publication-title: Res Nurs Health
  contributor:
    fullname: Sandelowski
– year: 2009
  ident: bib0003
  article-title: Accelerating the Development of Biomarkers for Drug Safety: Workshop Summary
– volume: 9
  start-page: 92
  year: 2017
  ident: bib0004
  article-title: Amnestic MCI patients' experiences after disclosure of their amyloid PET result in a research context
  publication-title: Alzheimers Res Ther
  contributor:
    fullname: Dierickx
– volume: 16
  start-page: 1330
  year: 2020
  end-page: 1337
  ident: bib0013
  article-title: A randomized controlled trial of amyloid positron emission tomography results disclosure in mild cognitive impairment
  publication-title: Alzheimers Dement
  contributor:
    fullname: Butters
– volume: 18
  start-page: 531
  year: 2022
  end-page: 533
  ident: bib0009
  article-title: Aducanumab: Appropriate use recommendations
  publication-title: Alzheimer's Dement
  contributor:
    fullname: Salloway
– volume: 18
  start-page: 179
  year: 1995
  end-page: 183
  ident: bib0014
  article-title: Sample size in qualitative research
  publication-title: Res. Nurs. Health
  contributor:
    fullname: Sandelowski
– volume: 100
  start-page: E264
  year: 2023
  end-page: E274
  ident: bib0020
  article-title: Impact of amyloid and Tau PET on changes in diagnosis and patient management
  publication-title: Neurology
  contributor:
    fullname: Takahata
– volume: 10
  start-page: 362
  year: 2023
  end-page: 377
  ident: bib0010
  article-title: Lecanemab: appropriate use recommendations
  publication-title: J Prev Alzheimers Dis
  contributor:
    fullname: Rabinovici
– volume: 10
  start-page: 413
  year: 2018
  end-page: 420
  ident: bib0007
  article-title: Amyloid positron emission tomography candidates may focus more on benefits than risks of results disclosure
  publication-title: Alzheimers Dement
  contributor:
    fullname: Kim
– volume: 5
  start-page: 245
  year: 2018
  end-page: 252
  ident: bib0008
  article-title: Clinical application of APOE in Alzheimer's prevention: a precision medicine approach
  publication-title: J Prev Alzheimers Dis
  contributor:
    fullname: Isaacson
– volume: 11
  start-page: 1367
  year: 2022
  ident: bib0017
  article-title: Blood-based biomarkers for Alzheimer's disease diagnosis and progression: an overview
  publication-title: Cells
  contributor:
    fullname: Pires
– volume: 131
  start-page: 1630
  year: 2008
  end-page: 1645
  ident: bib0015
  article-title: Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease
  publication-title: Brain
  contributor:
    fullname: Abrahamson
– volume: 46
  start-page: 791
  year: 2006
  end-page: 800
  ident: bib0016
  article-title: Making sense of mild cognitive impairment: a qualitative exploration of the patient's experience
  publication-title: Gerontologist
  contributor:
    fullname: DeKosky
– volume: 13
  start-page: 45
  year: 2017
  end-page: 58
  ident: bib0002
  article-title: Blood-based biomarkers in Alzheimer disease: current state of the science and a novel collaborative paradigm for advancing from discovery to clinic
  publication-title: Alzheimers Dement
  contributor:
    fullname: Rissman
– volume: 14
  start-page: 535
  year: 2018
  end-page: 562
  ident: bib0001
  article-title: NIA-AA Research Framework: toward a biological definition of Alzheimer's disease
  publication-title: Alzheimers Dement
  contributor:
    fullname: Blennow
– volume: 63
  start-page: 71
  year: 2023
  end-page: 81
  ident: bib0006
  article-title: Reactions to amyloid PET scan results and levels of anxious and depressive symptoms: CARE IDEAS study
  publication-title: Gerontologist
  contributor:
    fullname: Carroll
– volume: 10
  start-page: 101
  year: 2018
  ident: bib0018
  article-title: Study partners: essential collaborators in discovering treatments for Alzheimer's disease
  publication-title: Alzheimers Res Ther
  contributor:
    fullname: Grill
– volume: 5
  start-page: 245
  issue: 4
  year: 2018
  ident: 10.1016/j.gerinurse.2023.07.007_bib0008
  article-title: Clinical application of APOE in Alzheimer's prevention: a precision medicine approach
  publication-title: J Prev Alzheimers Dis
  contributor:
    fullname: Berkowitz
– volume: 23
  start-page: 334
  issue: 4
  year: 2000
  ident: 10.1016/j.gerinurse.2023.07.007_bib0012
  article-title: Whatever happened to qualitative description?
  publication-title: Res Nurs Health
  doi: 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G
  contributor:
    fullname: Sandelowski
– volume: 13
  start-page: 45
  issue: 1
  year: 2017
  ident: 10.1016/j.gerinurse.2023.07.007_bib0002
  article-title: Blood-based biomarkers in Alzheimer disease: current state of the science and a novel collaborative paradigm for advancing from discovery to clinic
  publication-title: Alzheimers Dement
  doi: 10.1016/j.jalz.2016.09.014
  contributor:
    fullname: O'Bryant
– volume: 131
  start-page: 1630
  issue: Pt 6
  year: 2008
  ident: 10.1016/j.gerinurse.2023.07.007_bib0015
  article-title: Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease
  publication-title: Brain
  doi: 10.1093/brain/awn016
  contributor:
    fullname: Ikonomovic
– volume: 10
  start-page: 101
  issue: 1
  year: 2018
  ident: 10.1016/j.gerinurse.2023.07.007_bib0018
  article-title: Study partners: essential collaborators in discovering treatments for Alzheimer's disease
  publication-title: Alzheimers Res Ther
  doi: 10.1186/s13195-018-0425-4
  contributor:
    fullname: Largent
– volume: 321
  start-page: 1286
  issue: 13
  year: 2019
  ident: 10.1016/j.gerinurse.2023.07.007_bib0019
  article-title: Association of amyloid positron emission tomography with subsequent change in clinical management among medicare beneficiaries with mild cognitive impairment or dementia
  publication-title: JAMA
  doi: 10.1001/jama.2019.2000
  contributor:
    fullname: Rabinovici
– volume: 63
  start-page: 71
  issue: 1
  year: 2023
  ident: 10.1016/j.gerinurse.2023.07.007_bib0006
  article-title: Reactions to amyloid PET scan results and levels of anxious and depressive symptoms: CARE IDEAS study
  publication-title: Gerontologist
  doi: 10.1093/geront/gnac051
  contributor:
    fullname: Bélanger
– volume: 46
  start-page: 791
  issue: 6
  year: 2006
  ident: 10.1016/j.gerinurse.2023.07.007_bib0016
  article-title: Making sense of mild cognitive impairment: a qualitative exploration of the patient's experience
  publication-title: Gerontologist
  doi: 10.1093/geront/46.6.791
  contributor:
    fullname: Lingler
– volume: 10
  start-page: 362
  year: 2023
  ident: 10.1016/j.gerinurse.2023.07.007_bib0010
  article-title: Lecanemab: appropriate use recommendations
  publication-title: J Prev Alzheimers Dis
  contributor:
    fullname: Cummings
– volume: 100
  start-page: E264
  issue: 3
  year: 2023
  ident: 10.1016/j.gerinurse.2023.07.007_bib0020
  article-title: Impact of amyloid and Tau PET on changes in diagnosis and patient management
  publication-title: Neurology
  doi: 10.1212/WNL.0000000000201389
  contributor:
    fullname: Shimohama
– volume: 56
  year: 1999
  ident: 10.1016/j.gerinurse.2023.07.007_bib0011
  article-title: Mild cognitive impairment: clinical characterization and outcome
  publication-title: Arch Neurol
  doi: 10.1001/archneur.56.3.303
  contributor:
    fullname: Petersen
– volume: 11
  start-page: 1367
  issue: 8
  year: 2022
  ident: 10.1016/j.gerinurse.2023.07.007_bib0017
  article-title: Blood-based biomarkers for Alzheimer's disease diagnosis and progression: an overview
  publication-title: Cells
  doi: 10.3390/cells11081367
  contributor:
    fullname: Varesi
– ident: 10.1016/j.gerinurse.2023.07.007_bib0005
  doi: 10.1002/trc2.12002
– volume: 16
  start-page: 1330
  issue: 9
  year: 2020
  ident: 10.1016/j.gerinurse.2023.07.007_bib0013
  article-title: A randomized controlled trial of amyloid positron emission tomography results disclosure in mild cognitive impairment
  publication-title: Alzheimers Dement
  doi: 10.1002/alz.12129
  contributor:
    fullname: Lingler
– volume: 9
  start-page: 92
  issue: 1
  year: 2017
  ident: 10.1016/j.gerinurse.2023.07.007_bib0004
  article-title: Amnestic MCI patients' experiences after disclosure of their amyloid PET result in a research context
  publication-title: Alzheimers Res Ther
  doi: 10.1186/s13195-017-0321-3
  contributor:
    fullname: Vanderschaeghe
– volume: 14
  start-page: 535
  issue: 4
  year: 2018
  ident: 10.1016/j.gerinurse.2023.07.007_bib0001
  article-title: NIA-AA Research Framework: toward a biological definition of Alzheimer's disease
  publication-title: Alzheimers Dement
  doi: 10.1016/j.jalz.2018.02.018
  contributor:
    fullname: Jack
– volume: 18
  start-page: 531
  year: 2022
  ident: 10.1016/j.gerinurse.2023.07.007_bib0009
  article-title: Aducanumab: Appropriate use recommendations
  publication-title: Alzheimer's Dement
  doi: 10.1002/alz.12444
  contributor:
    fullname: Cummings
– year: 2009
  ident: 10.1016/j.gerinurse.2023.07.007_bib0003
– volume: 18
  start-page: 179
  year: 1995
  ident: 10.1016/j.gerinurse.2023.07.007_bib0014
  article-title: Sample size in qualitative research
  publication-title: Res. Nurs. Health
  doi: 10.1002/nur.4770180211
  contributor:
    fullname: Sandelowski
– volume: 10
  start-page: 413
  year: 2018
  ident: 10.1016/j.gerinurse.2023.07.007_bib0007
  article-title: Amyloid positron emission tomography candidates may focus more on benefits than risks of results disclosure
  publication-title: Alzheimers Dement
  contributor:
    fullname: Lingler
SSID ssj0009383
Score 2.3570645
Snippet •Biomarker tests for Alzheimer's disease (AD) pathology are proliferating.•Pre-test counseling (PTC) for AD biomarker testing is an emerging role for...
Biomarker testing for Alzheimer's disease and related disorders (ADRD) brings new opportunities for nurses to foster shared decision-making by leading pre-test...
INTRODUCTIONBiomarker testing for Alzheimer's disease and related disorders (ADRD) brings new opportunities for nurses to foster shared decision-making by...
SourceID pubmedcentral
proquest
crossref
pubmed
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 130
SubjectTerms Alzheimer Disease - diagnosis
Alzheimer's disease
Amyloid PET
Biomarkers
Cognitive Dysfunction - psychology
Counseling
Humans
Mild cognitive impairment
Nurse's Role
Nurse-patient communication
Patient education
Positron-Emission Tomography - methods
Title Nurse-led pre-test counseling for Alzheimer's disease biomarker testing: Knowledge and skills required to meet the needs of patients and families
URI https://dx.doi.org/10.1016/j.gerinurse.2023.07.007
https://www.ncbi.nlm.nih.gov/pubmed/37540906
https://search.proquest.com/docview/2846925753
https://pubmed.ncbi.nlm.nih.gov/PMC10711726
Volume 53
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB61W4G4IFheC6UaJASndPNy4vS2qqgWqvYCFb1Fjh9taJqtkvTCgf_AP2acOAsLSBw4xvFEVjye-ez5ZgzwOuNhYDgzng2aeTEraElJ7nsmDZlgsSr8vk7ByWmyPIs_nLPzLTgcc2EsrdLZ_sGm99batczd35zflOX8I4GTNGYp-TdralO2DTvkjkI-gZ3F--Pl6c_au64aJ_X3rMAGzevCZtlZvsS-vUi8L-Rpr5b9u5P6E4T-zqX8xTkdPYD7DlXiYhj4Q9jS9RTunri4-RTuuEOBKewO-bj4WVdGNBrf4Niwaq4ewXfbUXuVVmj5IYRDO5TrtHUkhIuL6uulLq9187ZFF95Bm8RveT4NWgnqeYDH42Edilphe1VWVYuNtsRj-ni3wmutOyT4iTU50BZXBl2N17aX6E9eaBv_GM6O3n06XHru1gZPxmHYeSoqaM-pGedFaiQTOkwD4XMpkiwKAkV4yzBfpzKKMhUIZWQoTaJlYoKiEFGioycwqVe1fgZogiQk8B8aJU0sRMAVkypVXJs4I5wlZuCP05TfDMU58pG19iVfz2xuZzb3baA9ncHBOJ35hp7l5EL-LfxqVICcVqENrYhar27bnJx8kpH1Y9EMng4KsR6RvWTYz_xkBnxDVdYdbIXvzTd1edlX-qa9eUAIM3n-P6N-Affs00CM24VJ19zql4SkumIPtve_BXtuvfwA3lEitQ
link.rule.ids 230,315,783,787,888,4509,24128,27936,27937,45597,45691
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB6VVlAuCJZHFwoMEoJTunk5j95WFdWW7e6FVvQWOX7Q0DRbJemFf8E_Zpw4CwtIHLjansiKPTOfPd-MAd6mie_phGnHBM2ckOWkUiJxHR37jLNQ5m5Xp2CxjGbn4ccLdrEFR0MujKFVWtvf2_TOWtuWif2bk5uimHwicBKHLCb_ZkxtzO7ADqGBlLRzZ3oyny1_1t611ThpvGMENmheX0yWneFLHJiHxLtCnuZp2b87qT9B6O9cyl-c0_FDeGBRJU77iT-CLVWN4N7Cxs1HcNdeCoxgv8_Hxc-q1LxW-A6HhlV99Ri-m4HKKZVEww8hHNqiWKetIyFcnJbfLlVxrer3DdrwDpokfsPzqdFI0MhDnA-Xdcgric1VUZYN1soQj-nj7QqvlWqR4CdW5EAbXGm0NV6bTqK7eaFj_BM4P_5wdjRz7KsNjgh9v3VkkNOZU7EkyWMtGFd-7HE3ETxKA8-ThLc0c1UsgiCVHpda-EJHSkTay3MeRCp4CtvVqlJ7gNqLfAL_vpZCh5x7iWRCxjJROkwJZ_ExuMMyZTd9cY5sYK19zdYrm5mVzVwTaI_HcDgsZ7axzzJyIf8WfjNsgIy00IRWeKVWt01GTj5KyfqxYAzP-g2xnpF5ZNhN3WgMycZWWQ8wFb43e6risqv0TWdzjxBm9Px_Zv0admdni9Ps9GQ5fwH3TU9PktuH7ba-VS8JVbX5K6s1PwDheSSp
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Nurse-led+pre-test+counseling+for+Alzheimer%27s+disease+biomarker+testing%3A+Knowledge+and+skills+required+to+meet+the+needs+of+patients+and+families&rft.jtitle=Geriatric+nursing+%28New+York%29&rft.au=Greer%2C+Olivia&rft.au=Cheng%2C+Rebekah&rft.au=Tamres%2C+Lisa+K.&rft.au=Mattos%2C+Meghan&rft.date=2023-09-01&rft.pub=Elsevier+Inc&rft.issn=0197-4572&rft.eissn=1528-3984&rft.volume=53&rft.spage=130&rft.epage=134&rft_id=info:doi/10.1016%2Fj.gerinurse.2023.07.007&rft.externalDocID=S0197457223001775
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0197-4572&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0197-4572&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0197-4572&client=summon